Sublingual Administration of Captopril in Patients with Acute Myocardial Ischemia (Q28325791)

https://api.crossref.org/works/10.1002/CLC.4960140628

30 November 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140628

30 November 2022

author name string

M. Haude

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810682

30 November 2022

R. Erbel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810682

30 November 2022

W. Steffen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810682

30 November 2022

W. Tschollar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810682

30 November 2022

J. Meyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810682

full work available at URL

30 November 2022

language of work or name

English

0 references

publication date

June 1991

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fclc.4960140628

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140628

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.4960140628

30 November 2022

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140628

30 November 2022

0 references

14

0 references

issue

6

0 references

page(s)

463-8

0 references

cites work

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

The role of vasodilator therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Vasodilator therapy of cardiac failure: (first of two parts)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Improvement of chronic congestive heart-failure by oral captopril

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Effect of intracoronary captopril on coronary blood flow and regional myocardial function in dogs

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Acute effects of captopril on the coronary circulation of patients with hypertension and angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Tissue renin-angiotensin systems: focus on the heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Comparison of sublingual captopril and nifedipine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Hemodynamics after sublingual administration of captopril in severe heart failure. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140628

7 January 2021

Identification and characterization of functional angiotensin II receptors on cultured heart myocytes

22

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140628

30 November 2022

Identifiers

0 references